Brasil Pharma to carry out capital increase
Brasil Pharma poderá realizar um aumento de capital
Intel ID : 231314
| Synopsis |
|
Pharmacy chain Brasil Pharma (BVMF:PHA3), controlled by Banco BTG Pactual (BVMF:BPAC3), recommended a Public Offering of Common Shares to its Board, with restricted placement efforts, as reported by the company through a relevant fact published on 11 November 2015. The offer value would range between BRL 400m and BRL 600m, and would be made thorugh issuance of shares at a minimum price of BRL 0.40, or BRL 20 per group of shares.
(content in portuguese)
A rede de farmácias Brasil Pharma (BVMF:PHA3), controlada pelo Banco BTG Pactual (BVMF:BPAC3), recomendou ao Conselho de Administração a realização de uma oferta pública de distribuição de ações ordinárias de emissão da Companhia, com esforços restritos de colocação, segundo publicou a própria em Fato Relevante do dia 11 de novembro de 2015. O valor da oferta seria entre BRL 400m e BRL 600m mediante a emissão de ações com preço mínimo de BRL 0,40, ou BRL 20,00 por grupo de ações. |
Relevant Documents
| Notice / Relevant Fact | 11 Nov 2015 | BR_Pharma_Fato_Relevante_2015.pdf | PT |
|
| Intel ID | 231314 | ||
| Value | ND | ||
| Native Currency |
Brazilian Real (BRL)
Exchange Rate:  |
||
|
Financial Data - Brasil Pharma
(31 Dec 2018) |
Revenue: EUR 2,15m Exchange Rate:
|
||
| Date |
|
||
| Country |  |
||
| Region | |||
| Continent | |
||
| Geography | |
||
| Subsector (Old TTR Sectors) |
|
||
| Type |
|
||
| Intel Grade |
|
||
| Source |
|
||
| Tags | |
Issuer
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
25.04.03 Holding Companies / Financial Holding Companies 25 Financial Services / 25.04 Other Financial Services |
||
| Secondary Sectors (TTRSC) |
15.05.99 Other Distribution & Retail 15 Consumer Products & Services / 15.05 Distribution & Retail |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.